Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. MartensDOCMF +2.54%55 Future 3-5Y EPS without NRI Growth Rate is 20.74 as of Aug. 14, 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 138 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 63.04% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Dr. Martens's Future 3-5Y EPS without NRI Growth Rate is 20.74.
Dr. Martens (OTCPK:DOCMF) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Dr. Martens Future 3-5Y EPS without NRI Growth Rate Related Terms
DOCMF vs NKE, DECK, ONON: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Future 3-5Y EPS without NRI Growth Rate vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 20.74 mean?
Dr. Martens (DOCMF) has a Future 3-5Y EPS without NRI Growth Rate of 20.74 as of Aug. 14, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #51 out of 138 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 37%.
Is Dr. Martens' Future 3-5Y EPS without NRI Growth Rate too high?
Dr. Martens' current Future 3-5Y EPS without NRI Growth Rate is 20.74. The Manufacturing - Apparel & Accessories industry median Future 3-5Y EPS without NRI Growth Rate is 15.98. Dr. Martens' value of 20.74 is 29.8% above this industry median. Based on the distribution chart, Dr. Martens ranks #51 out of 138 companies in the Manufacturing - Apparel & Accessories industry, which is above the industry midpoint. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Future 3-5Y EPS without NRI Growth Rate compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #51 out of 138 companies for Future 3-5Y EPS without NRI Growth Rate. This puts Dr. Martens in the upper half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 15.98. Dr. Martens' value of 20.74 is 29.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Manufacturing - Apparel & Accessories company?
The median Future 3-5Y EPS without NRI Growth Rate among Manufacturing - Apparel & Accessories companies is 15.98, based on 138 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Future 3-5Y EPS without NRI Growth Rate of 20.74 is 29.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Future 3-5Y EPS without NRI Growth Rate is 15.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Future 3-5Y EPS without NRI Growth Rate is 20.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.97, compared to a current price of $1.21 — trading 24.7% above its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 20.74 and 29.8% above the Manufacturing - Apparel & Accessories industry median of 15.98. Dr. Martens' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Future 3-5Y EPS without NRI Growth Rate is 20.74 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of $1.21 is trading 24.7% above its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Modestly Overvalued.
Key valuation signals for DOCMF:
Future 3-5Y EPS without NRI Growth Rate: 20.74
GF Value™: $0.97 vs. price of $1.21 (24.7% above fair value)
Industry Position: 29.8% above the Manufacturing - Apparel & Accessories median (#51 of 138)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
